secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2023-07-11T23:59:59+00:00
Accession:  0001558370-23-011799
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn CEO resigns, returns as SVP; files $100M+ claim against former CRO Amarex
--------------------------------------------------------------------------------

- Dr. Cyrus Arman resigned as President and PEO on July 6, 2023; returns as SVP Business Operations with reduced salary of $300k.
- Antonio Migliarese continues as Interim President and CFO; board has begun search for new President/CEO.
- CytoDyn filed supplemental Statement of Claim against Amarex seeking damages exceeding $100M for alleged breach of CRO services.
- Under new agreement, Arman forfeited RSUs/PSUs; option to purchase 1,575,557 shares vests 40% immediately, rest over 6 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000155837023011799/0001558370-23-011799-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000155837023011799/cydy-20230706x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011799

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer